ID   MDCK.5F1
AC   CVCL_DE56
SY   BV-5F1; BV5F1
DR   Wikidata; Q54904804
RX   Patent=US20080254067;
RX   PubMed=10494965;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12042.
CC   Derived from sampling site: Kidney.
CC   Breed/subspecies: Cocker Spaniel.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 23-09-21; Version: 6
//
RX   Patent=US20080254067;
RA   Trepanier P., Dugre R., Hassell T.;
RT   "Process for the production of an influenza vaccine.";
RL   Patent number US20080254067, 16-Oct-2008.
//
RX   PubMed=10494965;
RA   Percheson P.B., Trepanier P., Dugre R., Mabrouk T.;
RT   "A phase I, randomized controlled clinical trial to study the
RT   reactogenicity and immunogenicity of a new split influenza vaccine
RT   derived from a non-tumorigenic cell line.";
RL   Dev. Biol. Stand. 98:127-132(1999).
//